Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 Study of Fluvoxamine in Pediatric/Adolescent Obsessive Compulsive Disorder
jRCT2080222216Phase 3
- Sponsor
- AbbVie Inc.
- Start
- Sep 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in obsessive compulsive disorder (OCD) comparing Fluvoxamine with Placebo (2 arms).
02
Drugs
fluvoxamine
03
Conditions
obsessive compulsive disorder (OCD)
Beyond the preview
Go deeper on jRCT2080222216.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080222216.